comparemela.com

Latest Breaking News On - Prove hf - Page 1 : comparemela.com

Sacubitril/Valsartan Improves Outcomes in Ischemic, Nonischemic Heart Disease

Using data from the PROVE-HF study, investigators conducted a subanalysis of outcomes among patients receiving sacubitril/valsartan who did and did not have ischemic heart disease.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.